Paper8840656
Prevalence of anti-HCV antibodies in central India.
Jaiswal SP and 6 others. Indian J Med Res, 1996. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Prevalence of anti-HCV antibodies in central India. Papers, record 8840656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8840656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis C | Major topic |
| Hepatitis C Antibodies | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Blood Donors | |
| Child | |
| Child, Preschool | |
| Female | |
| Hepatitis | |
| Humans | |
| India | |
| Kidney Failure, Chronic | |
| Male | |
| Mass Screening | |
| Middle Aged | |
| Prevalence | |
| Thalassemia |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27834318 | Combating the wrath of viral hepatitis in India. | Indian J Med Res | 2016 | https://conductscience.org/library/papers/27834318 | PubMed |
| 27194892 | Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India. | J Clin Exp Hepatol | 2016 | https://conductscience.org/library/papers/27194892 | PubMed |
| 26816888 | Hepatitis C Virus (HCV) Infection among Seronegative Patients undergoing Haemodialysis in a Remotely Located Tertiary Care Hospital of Northern India: Value of HCV-RNA and Genotypes. | J Clin Diagn Res | 2015 | https://conductscience.org/library/papers/26816888 | PubMed |
| 26060364 | Liver biopsy in patients on hemodialysis with hepatitis C virus infection: An important tool. | Indian J Nephrol | 2015 | https://conductscience.org/library/papers/26060364 | PubMed |
| 25883732 | Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria. | Pan Afr Med J | 2014 | https://conductscience.org/library/papers/25883732 | PubMed |
| 25755548 | Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. | J Clin Exp Hepatol | 2014 | https://conductscience.org/library/papers/25755548 | PubMed |
| 24959444 | Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors? | J Clin Diagn Res | 2014 | https://conductscience.org/library/papers/24959444 | PubMed |
| 21808124 | World Hepatitis Day--new challenges. | Indian J Med Res | 2011 | https://conductscience.org/library/papers/21808124 | PubMed |
| 20535258 | Authors' reply. | Indian J Nephrol | 2009 | https://conductscience.org/library/papers/20535258 | PubMed |
| 20535257 | Prevalence and association of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. | Indian J Nephrol | 2009 | https://conductscience.org/library/papers/20535257 | PubMed |
| 19208972 | Hepatitis C in India. | J Biosci | 2008 | https://conductscience.org/library/papers/19208972 | PubMed |
| 19147995 | Hepatitis C virus infection in haemodialysis: the 'no-isolation' policy should not be generalized. | Nephron Clin Pract | 2009 | https://conductscience.org/library/papers/19147995 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8840656
GET https://conductscience.org/api/papers/v1/8840656/authors